ArticleMolecular cancer therapeutics2014

Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Suhu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.